Inhibiting apoptosis of Schwann cell under the high-glucose condition: A promising approach to treat diabetic peripheral neuropathy using Chinese herbal medicine

Biomed Pharmacother. 2023 Jan:157:114059. doi: 10.1016/j.biopha.2022.114059. Epub 2022 Nov 30.

Abstract

Diabetic peripheral neuropathy (DPN) is a common complication of diabetes. Glycemic control and lifestyle alterations cannot prevent the development of DPN; therefore, investigating effective treatments for DPN is crucial. Schwann cells (SCs) maintain the physiological function of peripheral nerves and promote the repair and regeneration of injured nerves. Inhibiting the apoptosis of SCs through various pathological pathways in a high-glucose environment plays an important role in developing DPN. Therefore, inhibiting the apoptosis of SCs can be a novel treatment strategy for DPN. Previous studies have indicated the potential of Chinese herbal medicine (CHM) in treating DPN. In this study, we have reviewed the effects of CHM (both monomers and extracts) on the apoptosis of SCs by interfering with the production of advanced glycation end products, oxidative stress, and endoplasmic reticulum stress pathological pathways. This review will demonstrate the potentialities of CHM in inhibiting apoptosis in SCs, providing new insights and perspectives for treating DPN.

Keywords: Apoptosis; Chinese herbal medicine; Diabetic peripheral neuropathy; Schwann cells.

Publication types

  • Review

MeSH terms

  • Apoptosis
  • Diabetes Mellitus* / metabolism
  • Diabetic Neuropathies* / complications
  • Drugs, Chinese Herbal* / therapeutic use
  • Glucose / metabolism
  • Humans
  • Plant Extracts* / pharmacology
  • Schwann Cells

Substances

  • Glucose
  • Plant Extracts
  • Drugs, Chinese Herbal